Hubei Guangji Pharmaceutical Co Ltd (000952) — Cash Flow Reinvestment Rate
Hubei Guangji Pharmaceutical Co Ltd (000952) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting CN¥8.67 Million (capex CN¥8.67 Million ) from operating cash flow of CN¥22.38 Million. Check Hubei Guangji Pharmaceutical Co Ltd (000952) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Guangji Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Hubei Guangji Pharmaceutical Co Ltd across 20 annual periods. Explore long-term investment intensity of Hubei Guangji Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hubei Guangji Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Hubei Guangji Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 000952 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | CN¥35.64 Million | CN¥60.43 Million | CN¥35.64 Million | ▼ -99.9% |
| 2024 | 469.53x | CN¥307.71 Million | CN¥655.36K | CN¥154.93 Million | ▲ +7360.6% |
| 2022 | 6.29x | CN¥283.71 Million | CN¥45.08 Million | CN¥203.71 Million | ▲ +309.7% |
| 2021 | 1.54x | CN¥116.61 Million | CN¥75.91 Million | CN¥96.61 Million | ▲ +16.1% |
| 2020 | 1.32x | CN¥157.89 Million | CN¥119.38 Million | CN¥97.89 Million | ▲ +6.1% |
| 2019 | 1.25x | CN¥179.76 Million | CN¥144.20 Million | CN¥119.76 Million | ▲ +111.3% |
| 2018 | 0.59x | CN¥136.53 Million | CN¥231.44 Million | CN¥76.53 Million | ▼ -25.1% |
| 2017 | 0.79x | CN¥140.91 Million | CN¥178.83 Million | CN¥80.91 Million | ▼ -40.7% |
| 2016 | 1.33x | CN¥222.03 Million | CN¥167.07 Million | CN¥112.94 Million | ▲ +152.7% |
| 2013 | 0.53x | CN¥50.04 Million | CN¥95.16 Million | CN¥50.04 Million | ▼ -51.6% |
| 2012 | 1.09x | CN¥117.46 Million | CN¥108.02 Million | CN¥117.46 Million | ▼ -55.7% |
| 2011 | 2.45x | CN¥200.96 Million | CN¥81.88 Million | CN¥200.96 Million | ▲ +63.9% |
| 2010 | 1.50x | CN¥115.57 Million | CN¥77.18 Million | CN¥115.57 Million | ▲ +50.4% |
| 2008 | 1.00x | CN¥219.76 Million | CN¥220.70 Million | CN¥219.76 Million | ▲ +575.4% |
| 2007 | 0.15x | CN¥48.94 Million | CN¥331.98 Million | CN¥48.94 Million | ▼ -0.9% |
| 2006 | 0.15x | CN¥18.73 Million | CN¥125.95 Million | CN¥18.73 Million | ▼ -68.8% |
| 2005 | 0.48x | CN¥25.84 Million | CN¥54.14 Million | CN¥25.84 Million | ▼ -28.0% |
| 2002 | 0.66x | CN¥50.52 Million | CN¥76.20 Million | CN¥50.52 Million | ▲ +28.3% |
| 2000 | 0.52x | CN¥25.11 Million | CN¥48.57 Million | CN¥25.11 Million | ▼ -73.9% |
| 1999 | 1.98x | CN¥135.58 Million | CN¥68.57 Million | CN¥135.58 Million | — |